Dual targeting system by supramolecular complex of folate-conjugated methyl-β-cyclodextrin with adamantane-grafted hyaluronic acid for the treatment of colorectal cancer

International Journal of Biological Macromolecules - Tập 113 - Trang 386-394 - 2018
Khaled M. Elamin1, Keiichi Motoyama1, Taishi Higashi1, Yuki Yamashita1, Azumi Tokuda1, Hidetoshi Arima1,2
1Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan
2Program for Leading Graduate Schools “HIGO (Health life science: Interdisciplinary and Glocal Oriented) Program”, Kumamoto University, Japan

Tài liệu tham khảo

Jokerst, 2011, Molecular imaging with theranostic nanoparticles, Acc. Chem. Res., 44, 1050, 10.1021/ar200106e McCarthy, 2008, Multifunctional magnetic nanoparticles for targeted imaging and therapy, Adv. Drug Deliv. Rev., 60, 1241, 10.1016/j.addr.2008.03.014 Termsarasab, 2013, Chitosan oligosaccharide-arachidic acid-based nanoparticles for anti-cancer drug delivery, Int. J. Pharm., 441, 373, 10.1016/j.ijpharm.2012.11.018 Alexis, 2008, Factors affecting the clearance and biodistribution of polymeric nanoparticles, Mol. Pharm., 5, 505, 10.1021/mp800051m Yoo, 2011, Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery, Adv. Drug Deliv. Rev., 63, 1247, 10.1016/j.addr.2011.05.004 Bertrand, 2014, Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology, Adv. Drug Deliv. Rev., 66, 2, 10.1016/j.addr.2013.11.009 Maeda, 2013, The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo, Adv. Drug Deliv. Rev., 65, 71, 10.1016/j.addr.2012.10.002 Xu, 2015, Cancer nanomedicine: from targeted delivery to combination therapy, Trends Mol. Med., 21, 223, 10.1016/j.molmed.2015.01.001 Jono, 2011, Cyclodextrin, a novel therapeutic tool for suppressing amyloidogenic transthyretin misfolding in transthyretin-related amyloidosis, Biochem. J., 437, 35, 10.1042/BJ20110041 Vite, 2015, Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease, Sci. Transl. Med., 7, 276ra226, 10.1126/scitranslmed.3010101 Motoyama, 2005, Involvement of CD14 in the inhibitory effects of dimethyl‑α‑cyclodextrin on lipopolysaccharide signaling in macrophages, FEBS Lett., 579, 1707, 10.1016/j.febslet.2005.01.076 Arima, 2005, Inhibitory effects of dimethylacetyl‑β‑cyclodextrin on lipopolysaccharide-induced macrophage activation and endotoxin shock in mice, Biochem. Pharmacol., 70, 1506, 10.1016/j.bcp.2005.08.021 Yang, 2017, Cyclodextrin has conflicting actions on autophagy flux in vivo in brains of normal and Alzheimer model mice, Hum. Mol. Genet., 26, 843 Zimmer, 2016, Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming, Sci. Transl. Med., 8, 333ra350, 10.1126/scitranslmed.aad6100 Grosse, 1998, Antiproliferative effect of methyl-β-cyclodextrin in vitro and in human tumour xenografted athymic nude mice, Br. J. Cancer, 78, 1165, 10.1038/bjc.1998.648 Onodera, 2013, Involvement of cholesterol depletion from lipid rafts in apoptosis induced by methyl‑β‑cyclodextrin, Int. J. Pharm., 452, 116, 10.1016/j.ijpharm.2013.04.071 Yokoo, 2015, 2‑Hydroxypropyl‑β‑cyclodextrin acts as a novel anticancer agent, PLoS One, 10, 10.1371/journal.pone.0141946 Onodera, 2011, Design and evaluation of folate-appended methyl‑β‑cyclodextrin as a new antitumor agent, J. Incl. Phenom. Macrocycl. Chem., 70, 321, 10.1007/s10847-010-9843-z Onodera, 2013, Potential use of folate-appended methyl‑β‑cyclodextrin as an anticancer agent, Sci. Rep., 3, 1104, 10.1038/srep01104 Kameyama, 2017, Induction of mitophagy-mediated antitumor activity with folate-appended methyl‑β‑cyclodextrin, Int. J. Nanomedicine, 12, 3433, 10.2147/IJN.S133482 Suzuki, 2002, CD44 stimulation by fragmented hyaluronic acid induces upregulation and tyrosine phosphorylation of c-Met receptor protein in human chondrosarcoma cells, Biochim. Biophys. Acta, 1591, 37, 10.1016/S0167-4889(02)00246-X Miyake, 1998, Interaction between CD44 and hyaluronic acid regulates human prostate cancer development, J. Urol., 160, 1562, 10.1016/S0022-5347(01)62613-2 Hou, 2017, Killing colon cancer cells through PCD pathways by a novel hyaluronic acid-modified shell-core nanoparticle loaded with RIP3 in combination with chloroquine, Biomaterials, 124, 195, 10.1016/j.biomaterials.2016.12.032 Yang, 2016, Camptothecin–polysaccharide co-assembly and its controlled release, Bioconjug. Chem., 27, 2834, 10.1021/acs.bioconjchem.6b00606 Badwaik, 2016, Mechanistic insight into receptor-mediated delivery of cationic‑β‑cyclodextrin: hyaluronic acid-adamantamethamidyl host: guest pDNA nanoparticles to CD44+ cells, Mol. Pharm., 13, 1176, 10.1021/acs.molpharmaceut.6b00078 Elamin, 2017, Supramolecular complex of methyl‑β‑cyclodextrin with adamantane-grafted hyaluronic acid as a novel antitumor agent, Chem. Pharm. Bull. Oh, 2010, Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives, J. Control. Release, 141, 2, 10.1016/j.jconrel.2009.09.010 He, 2010, Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles, Biomaterials, 31, 3657, 10.1016/j.biomaterials.2010.01.065 Matsumura, 2009, Preclinical and clinical studies of anticancer agent-incorporating polymer micelles, Cancer Sci., 100, 572, 10.1111/j.1349-7006.2009.01103.x Maeda, 2000, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review, J. Control. Release, 65, 271, 10.1016/S0168-3659(99)00248-5 Zhang, 2016, A hyaluronidase-responsive nanoparticle-based drug delivery system for targeting colon cancer cells, Cancer Res., 76, 7208, 10.1158/0008-5472.CAN-16-1681 Nam, 2009, Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles, J. Control. Release, 135, 259, 10.1016/j.jconrel.2009.01.018 Doherty, 2009, Mechanisms of endocytosis, Annu. Rev. Biochem., 78, 857, 10.1146/annurev.biochem.78.081307.110540 Oommen, 2016, Multifunctional hyaluronic acid and chondroitin sulfate nanoparticles: impact of glycosaminoglycan presentation on receptor mediated cellular uptake and immune activation, ACS Appl. Mater. Interfaces, 8, 20614, 10.1021/acsami.6b06823 Contreras-Ruiz, 2011, Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells, Mol. Vis., 17, 279 Kondo, 2005, The role of autophagy in cancer development and response to therapy, Nat. Rev. Cancer, 5, 726, 10.1038/nrc1692 Onodera, 2014, Involvement of autophagy in antitumor activity of folate-appended methyl‑β‑cyclodextrin, Sci. Rep., 4, 4417, 10.1038/srep04417 Cheng, 2013, Therapeutic targeting of autophagy in disease: biology and pharmacology, Pharmacol. Rev., 65, 1162, 10.1124/pr.112.007120 Motoyama, 2017, Synthesis of multi-lactose-appended β‑cyclodextrin and its cholesterol-lowering effects in Niemann–Pick type C disease-like HepG2 cells, Beilstein J. Org. Chem., 13, 10, 10.3762/bjoc.13.2